Answers are grounded in this paper and cite their sources.
upregulation in 38% of basal tumors and 38% of inflammatory breast cancers (IBC). Upregulation, associated with signs of strong cytotoxic local immune response, was associated with a better survival in the basal or triple-negative subtypes, and with a better pathological response to chemotherapy in these subtypes and IBC. Reactivation of dormant tumor-infiltrating lymphocytes (TILs) by PD1/PDL1-inhibitors represents a promising strategy in these aggressive tumors.
No takes yet. Share an insight, caveat, or question.
Bertucci et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: